Skip to main content

Day: July 18, 2024

TGS Announces Extension to its Ocean Bottom Node Acquisition Campaign in West Africa

OSLO, Norway (July 18 2024) – TGS, a leading global provider of energy data and intelligence, is pleased to announce the extension of its’ deepwater Ocean Bottom Node (OBN) data acquisition campaign in West Africa. This additional program for a major customer will extend the ongoing acquisition cooperation well into Q4 2024. The project is expected to deliver industry leading seismic data thus providing the client with more informed decision making capabilities. Kristian Johansen, CEO at TGS, commented: “This continuing acquisition campaign demonstrates the vital role that OBN acquisition plays in providing our clients with superior seismic data. We are pleased to continue our efforts in West Africa and look forward to supporting our client’s needs with our advanced data solutions.” For more information, visit TGS.com or contact: Bård...

Continue reading

Junshi Biosciences Announces the Acceptance of the Supplemental New Drug Application for Toripalimab Combined with Bevacizumab for the First-Line Treatment of Advanced Hepatocellular Carcinoma

SHANGHAI, July 17, 2024 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the National Medical Products Administration (NMPA) has accepted for review the supplemental new drug application (sNDA) for toripalimab (trade name: TUOYI®, product code: JS001) combined with bevacizumab for the first-line treatment of unresectable or metastatic hepatocellular carcinoma (HCC). Liver cancer is a common malignant tumor of the digestive system worldwide, and the predominant pathological type is HCC (accounting for about 90% of global cases). According to the 2022 GLOBOCAN Report, there were 866,000 new cases and 759,000 deaths from liver cancer...

Continue reading

SAI.TECH Global Corporation Announces Share Repurchase Program

SINGAPORE, July 17, 2024 (GLOBE NEWSWIRE) — SAI.TECH Global Corporation (“SAI.TECH” or “SAI” or the “Company”) (NASDAQ: SAI, SAITW), today announced that its board of directors has authorized a new share repurchase program under which the Company may repurchase up to US$1 million and up to 1 million shares of its ordinary shares until January 11, 2025. The Company plans to adopt and implement this share repurchase program in accordance with applicable rules and requirements under the Securities Exchange Act of 1934, as amended, and the Company’s insider trading policies. The Company’s proposed repurchases may be made from time to time in the open market at prevailing market prices, in privately negotiated transactions, in block trades and/or through other legally permissible means, depending on market conditions and in accordance...

Continue reading

Condor Signs Its First LNG Framework Agreement in Kazakhstan

CALGARY, Alberta, July 17, 2024 (GLOBE NEWSWIRE) — Condor Energies Inc. (“Condor” or the “Company”) (TSX:CDR), a Canadian based energy transition company focused on providing stable and sustainable energy transition solutions, is pleased to announce the signing of its first LNG Framework Agreement (“Agreement”) for the utilization of liquefied natural gas (“LNG”) to fuel Kazakhstan’s rail locomotives. The Agreement was also signed by Kazakhstan Temir Zholy National Company JSC (“KTZ”), the national railway operator of the Republic of Kazakhstan (“Kazakhstan”) and Wabtec Corporation (“Wabtec”) (NYSE: WAB), a U.S. based locomotive manufacturer with existing facilities in Kazakhstan. KTZ and Wabtec previously signed a memorandum of understanding which includes modernization work to retrofit KTZ’s mainline locomotive fleet for LNG...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.